The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
3D Bioprinting-Global Market Insights and Sales Trends 2024
Synopsis
3D Bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics.
The global 3D Bioprinting market size is expected to reach US$ 33240 million by 2029, growing at a CAGR of 18.8% from 2023 to 2029. The market is mainly driven by the significant applications of 3D Bioprinting in various end use industries. The expanding demands from the Clinical Applications, Research Applications, Drug and Medical Research and Regenerative Medicine, are propelling 3D Bioprinting market. Magnetic 3D Bioprinting, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laser-assisted Bioprinting segment is estimated at % CAGR for the next seven-year period.
The global 3D bioprinting market is segmented into four broad categories, namely, microextrusion, inkjet, laser-assisted, and magnetic 3D bioprinting.The global inkjet based 3D bioprinting market is anticipated to reach 1423.5 million by 2025, at a CAGR of 21.3% from 2017 to 2025.Magnetic 3D bioprinting is expected to show the fastest growth during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for 3D Bioprinting, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global 3D Bioprinting market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global 3D Bioprinting market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, 3D Bioprinting sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of 3D Bioprinting covered in this report include Organovo Holdings Inc, EnvisionTEC GmbH, Nano3D Biosciences, Inc, Cyfuse Biomedical K.K, Advanced Solutions, Inc, Aspect Biosystems Ltd, 3Dynamic Systems Ltd, regenHU and Cellink, etc.
The global 3D Bioprinting market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Organovo Holdings Inc
EnvisionTEC GmbH
Nano3D Biosciences, Inc
Cyfuse Biomedical K.K
Advanced Solutions, Inc
Aspect Biosystems Ltd
3Dynamic Systems Ltd
regenHU
Cellink
Regenovo Biotechnology Co., Ltd
Poietis
GeSiM
Exone
Stratasys
Advanced BioMatrix
Ricoh Company Ltd
Global 3D Bioprinting market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global 3D Bioprinting market, Segment by Type:
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Global 3D Bioprinting market, by Application
Clinical Applications
Research Applications
Drug and Medical Research
Regenerative Medicine
3D Cell Culture
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of 3D Bioprinting companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
3D Bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics.
The global 3D Bioprinting market size is expected to reach US$ 33240 million by 2029, growing at a CAGR of 18.8% from 2023 to 2029. The market is mainly driven by the significant applications of 3D Bioprinting in various end use industries. The expanding demands from the Clinical Applications, Research Applications, Drug and Medical Research and Regenerative Medicine, are propelling 3D Bioprinting market. Magnetic 3D Bioprinting, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laser-assisted Bioprinting segment is estimated at % CAGR for the next seven-year period.
The global 3D bioprinting market is segmented into four broad categories, namely, microextrusion, inkjet, laser-assisted, and magnetic 3D bioprinting.The global inkjet based 3D bioprinting market is anticipated to reach 1423.5 million by 2025, at a CAGR of 21.3% from 2017 to 2025.Magnetic 3D bioprinting is expected to show the fastest growth during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for 3D Bioprinting, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global 3D Bioprinting market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global 3D Bioprinting market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, 3D Bioprinting sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of 3D Bioprinting covered in this report include Organovo Holdings Inc, EnvisionTEC GmbH, Nano3D Biosciences, Inc, Cyfuse Biomedical K.K, Advanced Solutions, Inc, Aspect Biosystems Ltd, 3Dynamic Systems Ltd, regenHU and Cellink, etc.
The global 3D Bioprinting market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Organovo Holdings Inc
EnvisionTEC GmbH
Nano3D Biosciences, Inc
Cyfuse Biomedical K.K
Advanced Solutions, Inc
Aspect Biosystems Ltd
3Dynamic Systems Ltd
regenHU
Cellink
Regenovo Biotechnology Co., Ltd
Poietis
GeSiM
Exone
Stratasys
Advanced BioMatrix
Ricoh Company Ltd
Global 3D Bioprinting market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global 3D Bioprinting market, Segment by Type:
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Global 3D Bioprinting market, by Application
Clinical Applications
Research Applications
Drug and Medical Research
Regenerative Medicine
3D Cell Culture
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of 3D Bioprinting companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of 3D Bioprinting
1.1 3D Bioprinting Market Overview
1.1.1 3D Bioprinting Product Scope
1.1.2 3D Bioprinting Market Status and Outlook
1.2 Global 3D Bioprinting Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global 3D Bioprinting Market Size by Region (2018-2029)
1.4 Global 3D Bioprinting Historic Market Size by Region (2018-2023)
1.5 Global 3D Bioprinting Market Size Forecast by Region (2024-2029)
1.6 Key Regions, 3D Bioprinting Market Size (2018-2029)
1.6.1 North America 3D Bioprinting Market Size (2018-2029)
1.6.2 Europe 3D Bioprinting Market Size (2018-2029)
1.6.3 Asia-Pacific 3D Bioprinting Market Size (2018-2029)
1.6.4 Latin America 3D Bioprinting Market Size (2018-2029)
1.6.5 Middle East & Africa 3D Bioprinting Market Size (2018-2029)
2 3D Bioprinting Market by Type
2.1 Introduction
2.1.1 Magnetic 3D Bioprinting
2.1.2 Laser-assisted Bioprinting
2.1.3 Inkjet 3D Bioprinting
2.1.4 Microextrusion 3D Bioprinting
2.2 Global 3D Bioprinting Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global 3D Bioprinting Historic Market Size by Type (2018-2023)
2.2.2 Global 3D Bioprinting Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America 3D Bioprinting Revenue Breakdown by Type (2018-2029)
2.3.2 Europe 3D Bioprinting Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific 3D Bioprinting Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America 3D Bioprinting Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa 3D Bioprinting Revenue Breakdown by Type (2018-2029)
3 3D Bioprinting Market Overview by Application
3.1 Introduction
3.1.1 Clinical Applications
3.1.2 Research Applications
3.1.3 Drug and Medical Research
3.1.4 Regenerative Medicine
3.1.5 3D Cell Culture
3.2 Global 3D Bioprinting Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global 3D Bioprinting Historic Market Size by Application (2018-2023)
3.2.2 Global 3D Bioprinting Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America 3D Bioprinting Revenue Breakdown by Application (2018-2029)
3.3.2 Europe 3D Bioprinting Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific 3D Bioprinting Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America 3D Bioprinting Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa 3D Bioprinting Revenue Breakdown by Application (2018-2029)
4 3D Bioprinting Competition Analysis by Players
4.1 Global 3D Bioprinting Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 3D Bioprinting as of 2022)
4.3 Date of Key Players Enter into 3D Bioprinting Market
4.4 Global Top Players 3D Bioprinting Headquarters and Area Served
4.5 Key Players 3D Bioprinting Product Solution and Service
4.6 Competitive Status
4.6.1 3D Bioprinting Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Organovo Holdings Inc
5.1.1 Organovo Holdings Inc Profile
5.1.2 Organovo Holdings Inc Main Business
5.1.3 Organovo Holdings Inc 3D Bioprinting Products, Services and Solutions
5.1.4 Organovo Holdings Inc 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.1.5 Organovo Holdings Inc Recent Developments
5.2 EnvisionTEC GmbH
5.2.1 EnvisionTEC GmbH Profile
5.2.2 EnvisionTEC GmbH Main Business
5.2.3 EnvisionTEC GmbH 3D Bioprinting Products, Services and Solutions
5.2.4 EnvisionTEC GmbH 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.2.5 EnvisionTEC GmbH Recent Developments
5.3 Nano3D Biosciences, Inc
5.3.1 Nano3D Biosciences, Inc Profile
5.3.2 Nano3D Biosciences, Inc Main Business
5.3.3 Nano3D Biosciences, Inc 3D Bioprinting Products, Services and Solutions
5.3.4 Nano3D Biosciences, Inc 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.3.5 Cyfuse Biomedical K.K Recent Developments
5.4 Cyfuse Biomedical K.K
5.4.1 Cyfuse Biomedical K.K Profile
5.4.2 Cyfuse Biomedical K.K Main Business
5.4.3 Cyfuse Biomedical K.K 3D Bioprinting Products, Services and Solutions
5.4.4 Cyfuse Biomedical K.K 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.4.5 Cyfuse Biomedical K.K Recent Developments
5.5 Advanced Solutions, Inc
5.5.1 Advanced Solutions, Inc Profile
5.5.2 Advanced Solutions, Inc Main Business
5.5.3 Advanced Solutions, Inc 3D Bioprinting Products, Services and Solutions
5.5.4 Advanced Solutions, Inc 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.5.5 Advanced Solutions, Inc Recent Developments
5.6 Aspect Biosystems Ltd
5.6.1 Aspect Biosystems Ltd Profile
5.6.2 Aspect Biosystems Ltd Main Business
5.6.3 Aspect Biosystems Ltd 3D Bioprinting Products, Services and Solutions
5.6.4 Aspect Biosystems Ltd 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.6.5 Aspect Biosystems Ltd Recent Developments
5.7 3Dynamic Systems Ltd
5.7.1 3Dynamic Systems Ltd Profile
5.7.2 3Dynamic Systems Ltd Main Business
5.7.3 3Dynamic Systems Ltd 3D Bioprinting Products, Services and Solutions
5.7.4 3Dynamic Systems Ltd 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.7.5 3Dynamic Systems Ltd Recent Developments
5.8 regenHU
5.8.1 regenHU Profile
5.8.2 regenHU Main Business
5.8.3 regenHU 3D Bioprinting Products, Services and Solutions
5.8.4 regenHU 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.8.5 regenHU Recent Developments
5.9 Cellink
5.9.1 Cellink Profile
5.9.2 Cellink Main Business
5.9.3 Cellink 3D Bioprinting Products, Services and Solutions
5.9.4 Cellink 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.9.5 Cellink Recent Developments
5.10 Regenovo Biotechnology Co., Ltd
5.10.1 Regenovo Biotechnology Co., Ltd Profile
5.10.2 Regenovo Biotechnology Co., Ltd Main Business
5.10.3 Regenovo Biotechnology Co., Ltd 3D Bioprinting Products, Services and Solutions
5.10.4 Regenovo Biotechnology Co., Ltd 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.10.5 Regenovo Biotechnology Co., Ltd Recent Developments
5.11 Poietis
5.11.1 Poietis Profile
5.11.2 Poietis Main Business
5.11.3 Poietis 3D Bioprinting Products, Services and Solutions
5.11.4 Poietis 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.11.5 Poietis Recent Developments
5.12 GeSiM
5.12.1 GeSiM Profile
5.12.2 GeSiM Main Business
5.12.3 GeSiM 3D Bioprinting Products, Services and Solutions
5.12.4 GeSiM 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.12.5 GeSiM Recent Developments
5.13 Exone
5.13.1 Exone Profile
5.13.2 Exone Main Business
5.13.3 Exone 3D Bioprinting Products, Services and Solutions
5.13.4 Exone 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.13.5 Exone Recent Developments
5.14 Stratasys
5.14.1 Stratasys Profile
5.14.2 Stratasys Main Business
5.14.3 Stratasys 3D Bioprinting Products, Services and Solutions
5.14.4 Stratasys 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.14.5 Stratasys Recent Developments
5.15 Advanced BioMatrix
5.15.1 Advanced BioMatrix Profile
5.15.2 Advanced BioMatrix Main Business
5.15.3 Advanced BioMatrix 3D Bioprinting Products, Services and Solutions
5.15.4 Advanced BioMatrix 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.15.5 Advanced BioMatrix Recent Developments
5.16 Ricoh Company Ltd
5.16.1 Ricoh Company Ltd Profile
5.16.2 Ricoh Company Ltd Main Business
5.16.3 Ricoh Company Ltd 3D Bioprinting Products, Services and Solutions
5.16.4 Ricoh Company Ltd 3D Bioprinting Revenue (US$ Million) & (2018-2023)
5.16.5 Ricoh Company Ltd Recent Developments
6 North America
6.1 North America 3D Bioprinting Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe 3D Bioprinting Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific 3D Bioprinting Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America 3D Bioprinting Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa 3D Bioprinting Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 3D Bioprinting Market Dynamics
11.1 3D Bioprinting Industry Trends
11.2 3D Bioprinting Market Drivers
11.3 3D Bioprinting Market Challenges
11.4 3D Bioprinting Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
